
Funder Type:
Funder Location: USA
Funder Linkedin: https://www.linkedin.com/in/bernhard-h-weigl/
Funder URL:
Funder Overview:
LEADER, INNOVATOR, INVENTOR
GLOBAL STRATEGY & INNOVATION LEADERSHIP – Directing large-scale diagnostics and health technology programs for emerging and low-resource markets within pharma and diagnostics industry ecosystems.
R&D PORTFOLIO & PRODUCT COMMERCIALIZATION – Translating inventions into regulatory agency-cleared (FDA, WHO PQ), market-ready, global products across infectious and non-communicable diseases.
CROSS-DISCIPLINARY TEAM LEADERSHIP – Managing global teams integrating biochemistry, engineering, data science, clinical trials, and regulatory compliance.
STAKEHOLDER PARTNERSHIPS & POLICY INFLUENCE – Engaging governments, NGOs, WHO, USAID, NIH, and BMGF to shape global health priorities and adoption pathways.
BIOTECH & STARTUP ADVISORY AND FRACTIONAL CTO – Currently working with biotech companies in the precision medicine and scientific wellness space and consultant in IP disputes, with expertise in technology transfer and commercialization.
DIAGNOSTICS PLATFORMS EXPERTISE – Microfluidics, digital droplet assays, immunoassays, nucleic acid assays, and point-of-care and AI-enabled home care rapid test technologies.
HEALTH DATA INTEGRATION – AI-guided patient-centered diagnostic interfaces for home and remote care using phone apps and self-collection and testing consumables
INFECTIOUS & CHRONIC DISEASE EXPERTISE – Deep domain knowledge in TB, malaria, cervical cancer, and diabetes diagnostics, coupled with policy and implementation experience.
CURRENT ROLES include co-Founder of UbiDx, and advisory roles at Bloodless Dx, Bowerlabs.ai, and LifeSADx, all aimed at rethinking diagnostics through novel sensing approaches, data integration, and scalable deployment models.
Investments/funding events:
Investment data is only available to paying subscribers or the owner of this funder profile.